Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0001577 (adnexitis)
 232 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In 215 cases of 2-phased artificial abortion with metreurynter, the Schatz-Hoehne model was inserted for 180 nulliparae and 35 multiparae. In comparison with a control group of 1145 1-phase artificial abortion cases, the metreurynter patients exhibited no intra- or postoperative bleeding, perforations, cervicorrhexis, or residua placenta. There were incidences of fever, endometritis, and salpingitis-adnexitis, which were, however, reversible and easily treated. The rate of complications in the metreurynter group was 5.58% compared with 5.67% in the control group. This method is recommended for early artificial termination of pregnancy (up to the 12th week) for women who have not given birth and where there are cervix dilatation difficulties.
 ...
PMID:[Experiences with the use of the metranoikter in interruption of pregnancy]. 481 45

Most infections occurring after an interruption of pregnancy (IP) are not due to the physician's negligence but rather to the patient's failure to follow treatment guidelines at home, especially their sexual activity and hygiene. The causes of secondary sterility were most often found to be parametritis with adnexitide or adnexitis on 1 or both sides. In a smaller percentage of cases there occurred salpingitis, cervicitis, colpitis, endometritis, and even pelveoperitonitis. It is not only infections that can cause sterility but disorders of the menstrual cycle (hypermenorrhagy, amenorrhagy) as well. The onset and the intensity of infection after IP is definitely dependent on the technique of the actual operation, the length of hospitalization, care at home after release from the hospital, and on the month of pregnancy when IP was performed.
 ...
PMID:[Long-term follow up of secondary sterility following artificial interruption of pregnancy]. 547 33

Clinical experiences with the DANA super IUD in 25 women are reporte d. No pregnancy occurred in the study group. Expulsion of the IUD occurred twice; reinsertion 2 months later was successful in both instances. Complications during the first 6 months included adnexitis, endometritis, hypermenorrhea, dysmenorrhea, and breakthrough bleeding. The IUD was removed in 1 case (acute adnexitis, treated with antibiotics). Menstrual complaints disappeared after the first 1-2 months. The authors recommend choosing the largest possible IUD for each woman, complete investigation and treatment of adnexitis before insertion, and strict asepsis during insertion.
 ...
PMID:[Clinical experiences with the intrauterine device "Dana-Super". (Preliminary report)]. 551 74

Using data from the 17th Congress of the Polish Gynecological Society of 1968, an analysis of complications following abortion at 2 obstetrical clinics in Poland is presented; the analysis covers a 10-year period beginning 2 years after the legalization of abortion in 1956. In the 1st clinic there were 3386 abortions (95% for social reasons), almost all performed during the first trimester. There were direct complications in 345 (10.2%) cases, delayed complications in 52 cases, but no deaths. At the 2nd clinic, 14,257 abortions were performed, and out of these there were 21 (.14%) cases of uterine perforation, 97 (.68%) cases of hemorrhage, 125 (.87%) of endometritis, 320 cases of adnexitis, 287 (2.01%) retained placentas, and 35 (.37%) cases of anemia. The use of a vacuum aspiration technique has demonstrably reduced complications. Since the legalization of abortion the mortality rate from complications is over 5 times less. Abortion is not without consequence to the organism, however, and stress is being placed on family planning and birth control.
 ...
PMID:[Analysis of complications after legal interruption of pregnancy in Poland]. 553 17

Sulbactam/cefoperazone (SBT/CPZ) was administered to 8 cases with gynecologic infections including pelvic peritonitis (2 cases), pyometra (2 cases), acute adnexitis, Bartholin abscess, endometritis and infected lymphocyst. The clinical efficacy was assessed as effective in 7 cases and poor in 1 case. The effective rate was 87.5%. No adverse reactions including clinical signs were observed. But slight elevation of GOT was observed in 1 case.
 ...
PMID:[Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology]. 609 11

The study was done to evaluate the usefulness of sulbactam/cefoperazone (SBT/CPZ) injection for the treatment of infections in the field of obstetrics and gynecology. Fundamental and clinical studies were made and the following results were obtained. In the clinical studies, SBT/CPZ was given to 19 cases with female genital organ infections. As for the clinical effects, responses were excellent in 4 cases, good in 15 cases among 19 cases in total. The efficacy rate was 100%. The efficacy rate on disease was 100% in all cases (9 cases of puerperal uterine infection, 1 case of endometritis, 1 case of pyometra, 5 cases of adnexitis, 2 cases of pelveoperitonitis and 1 case of abscess of vulva). As for causative bacteria, the efficacy rate was 100% for all infections due to single or mixed infection, due to aerobic Gram-negative, -positive or anaerobic bacteria. Side effect was observed in 1 case with diarrhea. SBT/CPZ showed a satisfactory clinical efficacy and a potent bacteriological effect in treatment of the infection in the field of obstetrics and gynecology, and it has been concluded that SBT/CPZ will be a useful addition to the antibiotics for the therapy of these infections.
 ...
PMID:[Fundamental and clinical studies of sulbactam/cefoperazone in obstetrics and gynecology]. 609 17

Fundamental and clinical studies on ceftriaxone (CTRX, Ro 13-9904), a new cephalosporin antibiotic, were carried out with the following results. Concentration of CTRX was examined in serum, internal genital organs and retroperitoneal fluid after single intravenous administration of 1.0 g dose. The venous serum level of CTRX was 156 micrograms/ml at 5 minutes after the administration. The favorable transfer of CTRX to internal genital organs and retroperitoneal fluid was demonstrated. In clinical trial, CTRX was given to 10 cases with obstetrical and gynecological infections such as endometritis, adnexitis, pelvic peritonitis and parametritis. The efficacy was evaluated as excellent in 1 case, good in 8 cases and poor in 1 case. No side effects were observed in any of the cases treated with CTRX.
 ...
PMID:[Fundamental and clinical studies on ceftriaxone in the field of obstetrics and gynecology]. 609 29

An analysis is presented of a study of the Copper-T 200 (CuT 200) IUD at the Barros Luco Hospital in Santiago, Chile over the August 16, 1976 June 30, 1978 period. 1142 IUDs were inserted in postpartum women, the majority of whom (96.1%) received their IUDs within 72 hours of giving birth. Data were recorded on standard forms designed to obtain demographic and medical information and were processed by the International Fertility Research Program (IFRP). The CuT 200 used in this study consisted of a plastic T-shaped device with 200 sq mm of copper wire wound around the vertical arm. The mean age of women in this study was 24.0 years; the mean number of live births was 2.4 57 (5.0%) of the women reported having had 1 or more induced abortions. There was no previous incidence of pelvic inflammatory disease (PID) reported by the patients, and none of them showed evidence of inflammation/infection of the genital organs at the time of insertion. There were no complications or complaints reported for women at insertion. There were no complications or complaints reported for women at insertion. 945 (82.7%) patients returned for 1 or more follow-up visits. Cervical perforation was found at follow-up in 2 (0.2%) women, and 9 (0.7%) women were hospitalized during the study period. From this latter group, women were hospitalized because of retained placentas and 2 women because of a perineotomy infection. 4 women were hospitalized for endometritis and 1 for the spontaneous abortion of a pregnancy conceived with the IUD in situ. 158 (13.8%) women were diagnosed as having 1 or more incidents of inflammation/infection. Included among these were 19 (1.7%) cases of adnexitis and 20 (1.8%) cases of endometritis. Dysmenorrhea was reported by 23.7% of the women. Intermenstrual bleeding/pain was reported by 297 (20.0%) of the women and 113 (9.9%) reported intermenstrual spotting. The continuation rate after 1 year was 55.5. The 3 month termination rates were 0.3 for accidental pregnancy, 32.1 for expulsion/displacement, 0.2 for bleeding/pain, and 1.3 for other medical reasons. Most expulsions occurred within 1 month postinsertion. 372 (32.6%) women who received CuT 200s in this study expelled them; 370 of them received a replacement IUD. 349 received a 2nd CuT 200 and 21 received Lippes Loop IUDs. 92.8% of the women who received replacement CuT 200s returned for follow-up and were diagnosed as having 1 or more infections. 19 of the women who expelled their 1st CuT and received a replacement also expelled their 2nd device and had a 3rd CuT 200 inserted. No complications or complaints were reported at insertion for this group. At follow-up 4 women were diagnosed with trichmonas and 1 with an unspecified inflammation/infection. 7 women expelled their IUDs and 1 woman had her IUD removed for other personal reasons.
 ...
PMID:Preliminary report on a postpartum CuT 200 study, Santiago, Chile. 613 98

Fundamental and clinical studies were made on piperacillin (PIPC) and the results were obtained as follows. Serum and uterine tissue concentrations of PIPC were obtained from 36 to 215 minutes after intravenous single shot of 2 g of PIPC. The cervix uteri, endometrium and corpus uteri showed the highest antibiotic levels of 38.0, 43.0 and 33.0 mcg/g, respectively, at 65 minutes after injection, and oviduct and ovary showed the highest level of 31.5 and 28.5 mcg/g at 36 minutes. Its concentrations were sufficiently effective against the major pathogens (Gram-negative bacilli and anaerobes) demonstrated in the field of obstetrics and gynecology. PIPC was administered 6 patients, including 3 of pelvic peritonitis (isolated organism was E. coli 1), 2 of acute endometritis (Klebsiella sp. 1, Peptococcus sp. + Bacteroides sp. 1) and 1 of acute adnexitis, in a dosage of 1 or 2 g twice or 3 times a day for a period of 5 to 8 days by intravenous administration or intravenous drip infusion. Clinical response was obtained excellent in 1 and good in 5. No adverse reaction as observed in any of the cases treated with PIPC, nor was there any marked changes in the laboratory findings.
 ...
PMID:[Fundamental and clinical studies on piperacillin in the field of obstetrics and gynecology]. 621 52

Ceftazidime ( CAZ ) was evaluated for its clinical efficacy in a total of 12 cases, namely 3 cases of endometritis, 3 cases of intrapelvic infections, 4 cases of adnexitis and 2 cases of external genital infections. In all the cases, CAZ was administered by intravenous drip infusion, and the duration of the treatment ranged from 3 to 22 days. Daily dose was 2 g in 10 cases, and in the remaining 2 cases, daily doses were changed during the course of treatment in the range from 2 to 4 g. The clinical results of CAZ by disease were as follows; excellent in 1 case and good in 2 cases of endometritis, good in all the 3 cases of intrapelvic infections and the 4 cases of adnexitis, and excellent in 1 case and good in 1 case of external genital infections. The overall efficacy rate was 100%, namely, excellent in 2 cases and good in 10 cases of the total of 12 cases. Neither side effects nor abnormal laboratory findings attributable to CAZ were observed in any of the case. From these results, we may conclude that CAZ is a safe antibiotic with satisfactory clinical effects on gynecological infections.
 ...
PMID:[Clinical efficacy of ceftazidime in inflammatory diseases in the field of gynecology]. 637 90


<< Previous 1 2 3 4 5 Next >>